PT1706383E - Sal de amina de um derivado de carboestirilo útil para o tratamento de inter alia, úlcera gástrica - Google Patents
Sal de amina de um derivado de carboestirilo útil para o tratamento de inter alia, úlcera gástrica Download PDFInfo
- Publication number
- PT1706383E PT1706383E PT57041444T PT05704144T PT1706383E PT 1706383 E PT1706383 E PT 1706383E PT 57041444 T PT57041444 T PT 57041444T PT 05704144 T PT05704144 T PT 05704144T PT 1706383 E PT1706383 E PT 1706383E
- Authority
- PT
- Portugal
- Prior art keywords
- treatment
- inter alia
- amine salt
- gastric ulcer
- derivative useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Quinoline Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004013402 | 2004-01-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1706383E true PT1706383E (pt) | 2015-10-15 |
Family
ID=34805383
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT57041444T PT1706383E (pt) | 2004-01-21 | 2005-01-20 | Sal de amina de um derivado de carboestirilo útil para o tratamento de inter alia, úlcera gástrica |
PT10174397T PT2253619E (pt) | 2004-01-21 | 2005-01-20 | Sal de amina de um derivado de carboestirilo |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT10174397T PT2253619E (pt) | 2004-01-21 | 2005-01-20 | Sal de amina de um derivado de carboestirilo |
Country Status (23)
Country | Link |
---|---|
US (2) | US7732611B2 (pt) |
EP (2) | EP2253619B1 (pt) |
JP (1) | JP4516962B2 (pt) |
KR (1) | KR100844762B1 (pt) |
CN (1) | CN1934086B (pt) |
AR (1) | AR047438A1 (pt) |
AT (1) | ATE549318T1 (pt) |
AU (1) | AU2005206430B2 (pt) |
BR (1) | BRPI0506982A (pt) |
CA (1) | CA2553231C (pt) |
CY (2) | CY1112723T1 (pt) |
DK (2) | DK2253619T3 (pt) |
ES (2) | ES2382133T3 (pt) |
HK (2) | HK1101327A1 (pt) |
HU (1) | HUE027990T2 (pt) |
MY (1) | MY148416A (pt) |
PL (2) | PL1706383T3 (pt) |
PT (2) | PT1706383E (pt) |
RU (1) | RU2372336C2 (pt) |
SG (1) | SG149854A1 (pt) |
SI (2) | SI1706383T1 (pt) |
TW (1) | TWI340650B (pt) |
WO (1) | WO2005070892A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6187197B1 (en) * | 1998-10-28 | 2001-02-13 | Marvin Haddock | Multi-stage engine coolant recycling process |
TWI340650B (en) * | 2004-01-21 | 2011-04-21 | Otsuka Pharma Co Ltd | Amine saly of carbostyril derivative |
MY157582A (en) * | 2007-08-10 | 2016-06-30 | Otsuka Pharma Co Ltd | Medical composition containing rebamipipe |
WO2009126695A2 (en) * | 2008-04-08 | 2009-10-15 | Dynamis Therapeutics, Inc. | Method for treating or preventing dry eye disorders using alkylamino-polyhydroxyalkanes |
RU2538694C2 (ru) * | 2008-06-19 | 2015-01-10 | Оцука Фармасьютикал Ко., Лтд. | Фармацевтическая композиция |
WO2012114317A1 (en) * | 2011-02-25 | 2012-08-30 | Nuformix Limited | Novel rebamipide complexes and cocrystals |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS517614Y2 (pt) * | 1971-02-12 | 1976-03-01 | ||
JPS597168A (ja) | 1982-07-05 | 1984-01-14 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体 |
US4578381A (en) * | 1982-07-05 | 1986-03-25 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
DK0543018T3 (da) * | 1991-06-07 | 1996-02-05 | Otsuka Pharma Co Ltd | Antidiabetikum |
TW227558B (pt) * | 1992-05-14 | 1994-08-01 | Otsuka Pharma Co Ltd | |
US5415872A (en) * | 1992-06-22 | 1995-05-16 | Digestive Care Inc. | Compositions of gastric acid-resistant microspheres containing salts of bile acids |
JP2872546B2 (ja) * | 1992-11-26 | 1999-03-17 | 大塚製薬株式会社 | 腸粘膜障害保護剤 |
JP2839847B2 (ja) * | 1993-10-21 | 1998-12-16 | 大塚製薬株式会社 | インターロイキン−8産生抑制剤 |
WO1995012579A1 (en) | 1993-11-05 | 1995-05-11 | Otsuka Pharmaceutical Company, Limited | Bismuth salt of carbostyril derivatives for the treatment of peptic ulcers |
JP3621463B2 (ja) | 1995-04-26 | 2005-02-16 | 大塚製薬株式会社 | カルボスチリル誘導体ビスマス塩 |
AR004214A1 (es) | 1995-10-12 | 1998-11-04 | Otsuka Pharma Co Ltd | Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas |
GB9613455D0 (en) | 1996-06-27 | 1996-08-28 | Aston Molecules Ltd | Analogues or derivatives of quercetin |
EP1483232A1 (en) | 2002-03-11 | 2004-12-08 | Novartis AG | Salts of nateglinide |
KR20040104020A (ko) | 2003-06-02 | 2004-12-10 | 진양제약주식회사 | 신규 레바미피드 리지네이트와 레바미피드 아르기니네이트및 이 신규 레바미피드 리지네이트와 레바미피드아르기니네이트를 유효성분으로 함유하는 약학적 제제 |
TWI340650B (en) * | 2004-01-21 | 2011-04-21 | Otsuka Pharma Co Ltd | Amine saly of carbostyril derivative |
JP4719917B2 (ja) | 2007-03-30 | 2011-07-06 | 国立大学法人 岡山大学 | アズキ加工食品のアズキ原料品種判定方法 |
-
2005
- 2005-01-18 TW TW094101386A patent/TWI340650B/zh not_active IP Right Cessation
- 2005-01-19 MY MYPI20050200A patent/MY148416A/en unknown
- 2005-01-20 DK DK10174397.9T patent/DK2253619T3/da active
- 2005-01-20 SI SI200531992T patent/SI1706383T1/sl unknown
- 2005-01-20 AT AT10174397T patent/ATE549318T1/de active
- 2005-01-20 WO PCT/JP2005/001034 patent/WO2005070892A1/en active Application Filing
- 2005-01-20 SG SG200900369-0A patent/SG149854A1/en unknown
- 2005-01-20 JP JP2006520510A patent/JP4516962B2/ja active Active
- 2005-01-20 BR BRPI0506982-3A patent/BRPI0506982A/pt not_active IP Right Cessation
- 2005-01-20 DK DK05704144.4T patent/DK1706383T3/en active
- 2005-01-20 PL PL05704144T patent/PL1706383T3/pl unknown
- 2005-01-20 ES ES10174397T patent/ES2382133T3/es active Active
- 2005-01-20 CA CA2553231A patent/CA2553231C/en not_active Expired - Fee Related
- 2005-01-20 CN CN2005800086478A patent/CN1934086B/zh not_active Expired - Fee Related
- 2005-01-20 KR KR1020067016600A patent/KR100844762B1/ko active IP Right Grant
- 2005-01-20 PT PT57041444T patent/PT1706383E/pt unknown
- 2005-01-20 PL PL10174397T patent/PL2253619T3/pl unknown
- 2005-01-20 PT PT10174397T patent/PT2253619E/pt unknown
- 2005-01-20 AR ARP050100199A patent/AR047438A1/es not_active Application Discontinuation
- 2005-01-20 RU RU2006129945/04A patent/RU2372336C2/ru not_active IP Right Cessation
- 2005-01-20 US US10/586,453 patent/US7732611B2/en not_active Expired - Fee Related
- 2005-01-20 SI SI200531494T patent/SI2253619T1/sl unknown
- 2005-01-20 EP EP10174397A patent/EP2253619B1/en not_active Not-in-force
- 2005-01-20 EP EP05704144.4A patent/EP1706383B1/en not_active Not-in-force
- 2005-01-20 ES ES05704144.4T patent/ES2544327T3/es active Active
- 2005-01-20 AU AU2005206430A patent/AU2005206430B2/en not_active Ceased
- 2005-01-20 HU HUE05704144A patent/HUE027990T2/en unknown
-
2007
- 2007-08-24 HK HK07109247.5A patent/HK1101327A1/xx not_active IP Right Cessation
-
2010
- 2010-04-26 US US12/662,610 patent/US8222276B2/en not_active Expired - Fee Related
-
2011
- 2011-03-17 HK HK11102692.4A patent/HK1148527A1/xx not_active IP Right Cessation
-
2012
- 2012-05-11 CY CY20121100442T patent/CY1112723T1/el unknown
-
2015
- 2015-10-06 CY CY20151100891T patent/CY1116773T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2327A (en) | Quinoline derivatives for the treatment of latent tuberculosis. | |
AP2321A (en) | Quinoline derivatives for use as mycobactrial inhibitor. | |
SG10201508623RA (en) | Crystals of laquinimod sodium, and process for the manufacture thereof | |
AP2007004157A0 (en) | N- (N-sulfonylaminomethyl) cyclo-propanecarboxamide derivatives useful for the treatment of pain | |
EP1830876A4 (en) | TREATMENT OF SKIN METASTASES | |
IL208963A0 (en) | Substituted quinoline compounds | |
IL181897A0 (en) | Cyclic amine derivative or salt thereof | |
HK1101587A1 (en) | Method for the preparation of d-erythro-2,2-difluoro-2-deoxy-1-oxoribose derivative | |
SI1706383T1 (sl) | Sol amina derivata karbostirila uporabna za zdravljenje, med drugim, želodčne razjede | |
ZA200703495B (en) | Process for the preparation of irbesartan hydrochloride | |
ZA200805159B (en) | Imidazole derivatives for the treatment of gastrointestinal disorders | |
PL377464A1 (pl) | Aminoalkoksyindole jako ligandy receptora 5-HT6 do leczenia zaburzeń OUN | |
IL172126A0 (en) | Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection | |
IL181332A0 (en) | Prostaglandin derivatives for treating gastrointestinal disorder | |
EP1919871A4 (en) | PROCESS FOR SYNTHESIS OF CHINOLINE DERIVATIVES | |
ZA200705160B (en) | Quinoline derivatives for the treatment of latent tuberculosis | |
ZA200605575B (en) | Substituted quinoline compounds | |
IL174043A0 (en) | 2-alkylidene-19-nor-vitamin d derivatives for the treatment of frailty, muscle damage or sarcopenia | |
ZA200702625B (en) | Prostaglandin derivatives for treating gastrointestinal disorder | |
ZA200702193B (en) | 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds | |
GB0428061D0 (en) | Novel Quinoline Compounds | |
SM200500001A (it) | Apparecchiatura retroazionata per l'elettrostimolazione |